Asia Pacific Cardiac Microcatheter Market Forecast to 2028- COVID-19 Impact and Regional Analysis- by Indication (General Peripheral Vascular and Coronary) and End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers)

List of Tables

The Asia Pacific cardiac microcatheter market is expected to grow from US$ 80.47 million in 2023 to US$ 114.76 million by 2028. It is estimated to grow at a CAGR of 7.4% from 2023 to 2028.

Surge in New Product Approvals, Launches, and Awareness in Field of Cardiac Microcatheter Fuel Asia Pacific Cardiac Microcatheter Market

As a coronary interventional tool, microcatheters support the performance of invasive endovascular procedures by fulfilling a wide range of functions in complex vascular anatomies. Manufacturers across the world are investing in research and development of advanced technologies, which has led to the development of new and advanced products, along with a surge in product approvals. A few product approvals and developments are listed below ; In 2019, Navitian, a new coronary microcatheter from iVascular, received the CE mark approval. The device was approved to facilitate, guide, and support a guidewire while accessing the coronary system, exchanging guidewires, and injecting radiopaque contrast media or saline solutions. In 2020, Acist Medical Systems Inc., a Bracco Group Company, announced the global launch of its Acist Navvus II Rapid Exchange fractional flow reserve (FFR) microcatheter, the second-generation microcatheter for use with its Acist RXi Rapid Exchange FFR System. FFR measurements assess arterial lesion severity and the intervention strategies in diagnosing and treating coronary artery disease. In May 2023, Acotec Scientific Holdings Ltd. received Chinese marketing approval for its microcatheter Vericor-14 to assist in percutaneous coronary interventions and percutaneous peripheral interventions, taking a step ahead in a competitive market that is poised to grow eightfold by the end of the decade.

Therefore, a surge in new product approvals, launches, and awareness in the field of cardiac microcatheter is expected to fuel the cardiac microcatheter market growth during the forecast period.

Asia Pacific Cardiac Microcatheter Market Overview

The Asia Pacific cardiac microcatheter market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The region occupies a significant position in the Asia Pacific cardiac microcatheter market and is expected to demonstrate a promising growth trajectory during the forecast period. The driving factors for the growth of the market are increasing prevalence of cardiovascular diseases, growing aging population, improving healthcare infrastructure, and rising awareness about minimally invasive procedures.

Asia Pacific Cardiac Microcatheter Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Cardiac Microcatheter Market Segmentation

The Asia Pacific cardiac microcatheter market is segmented into indication, end user, and country.

Based on indication, the Asia Pacific cardiac microcatheter market is segmented into general peripheral vascular and coronary. The coronary segment held a larger share of the Asia Pacific cardiac microcatheter market in 2023.

Based on end user, the Asia Pacific cardiac microcatheter market is segmented into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment held the largest share of the Asia Pacific cardiac microcatheter market in 2023.

Based on country, the Asia Pacific cardiac microcatheter market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the share of the Asia Pacific cardiac microcatheter market in 2023.

Boston Scientific Corp; Integer Holdings Corp; Medtronic Plc; Merit Medical Systems Inc; Nipro Corp; OrbusNeich Medical Group Holdings Ltd; Teleflex Inc; Terumo Corp; and Tokai Medical Products Inc are the leading companies operating in the Asia Pacific cardiac microcatheter market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific cardiac microcatheter market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific cardiac microcatheter market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: BMIRE00028749

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Asia Pacific Cardiac Microcatheter Market - by Indication
- 1.3.2 Asia Pacific Cardiac Microcatheter Market - by End User
- 1.3.3 Asia Pacific Cardiac Microcatheter Market - by Country

2. Asia Pacific Cardiac Microcatheter Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Cardiac Microcatheter Market - Market Landscape

4.1 Overview
4.2 Asia Pacific PEST Analysis
4.3 Experts' Opinion

5. Asia Pacific Cardiac Microcatheter Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Cardiovascular Diseases
- 5.1.2 Growing Use of Percutaneous Coronary Intervention (PCI) for Treating Chronic Total Occlusions (CTO)
5.2 Market Restraints
- 5.2.1 Complications and Failures Related to Usage of Cardiac Microcatheter
5.3 Market Opportunity
- 5.3.1 Increasing Healthcare Spending and Government-led Initiatives Regarding Heart Health
5.4 Future Trends
- 5.4.1 Surge in New Product Approvals, Launches, and Awareness in Field of Cardiac Microcatheter
5.5 Impact Analysis of Drivers and Restraints

6. Cardiac Microcatheter Market - Asia Pacific Analysis

6.1 Asia Pacific Cardiac Microcatheter Market Revenue Forecast and Analysis

7. Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 - by Indication

7.1 Overview
7.2 Coronary
- 7.2.1 Overview
- 7.2.2 Coronary: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
7.3 General Peripheral Vascular
- 7.3.1 Overview
- 7.3.2 General Peripheral Vascular: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Cardiac Microcatheter Market Analysis - by End User

8.1 Overview
8.2 Hospitals
- 8.2.1 Overview
- 8.2.2 Hospitals: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
8.3 Ambulatory Surgical Centers
- 8.3.1 Overview
- 8.3.2 Ambulatory Surgical Centers: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Specialty Clinics
- 8.4.1 Overview
- 8.4.2 Specialty Clinics: Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Cardiac Microcatheter Market - Revenue and Forecast to 2028 - Country Analysis

9.1 Overview

10. Asia Pacific Cardiac Microcatheter Market - Industry Landscape

10.1 Overview
10.2 Organic Developments
- 10.2.1 Overview

11. Company Profiles

11.1 Boston Scientific Corp
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Teleflex Inc
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Medtronic Plc
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 OrbusNeich Medical Group Holdings Ltd
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Merit Medical Systems Inc
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Nipro Corp
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Terumo Corp
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Tokai Medical Products Inc
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 Integer Holdings Corp
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments

12. Appendix

12.1 About The Insight Partners
12.2 Glossary of Terms